ARTICLE | Clinical News
Atopiclair dermatology data
December 4, 2006 8:00 AM UTC
In a double-blind trial in 40 patients aged 2-17, Atopiclair met the primary and secondary endpoints. On the primary endpoint, 80% of patients taking Atopiclair were considered treatment successes aft...